Xu N - Search Results

1

The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.

Dong Y, Bi LR, Xu N, Yang HM, Zhang HT, Ding Y, Shi AP, Fan ZM. Dong Y, et al. Among authors: xu n. Pathol Res Pract. 2013 Sep;209(9):555-61. doi: 10.1016/j.prp.2013.05.007. Epub 2013 Jun 14. Pathol Res Pract. 2013. PMID: 23916993

2

Clinical features and prognosis of a unilateral fibroadenoma of the breast in a 16-month-old female.

Shi A, Li S, Xu N, Nie G, Li X, Zhang T, Fan Z. Shi A, et al. Among authors: xu n. Jpn J Clin Oncol. 2011 Feb;41(2):260-4. doi: 10.1093/jjco/hyq181. Epub 2010 Oct 11. Jpn J Clin Oncol. 2011. PMID: 20937600

3

Renal primitive malignant tumor with endocrine activity.

Xu N, Jin MS, Chen L, Wang CX, Sun ST, Shi AP. Xu N, et al. Med Princ Pract. 2013;22(2):200-3. doi: 10.1159/000342194. Epub 2012 Sep 5. Med Princ Pract. 2013. PMID: 22964717 Free PMC article.

4

Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.

Xu N, Shao MM, Zhang HT, Jin MS, Dong Y, Ou RJ, Wang HM, Shi AP. Xu N, et al. Cancer Epidemiol. 2015 Jun;39(3):375-81. doi: 10.1016/j.canep.2015.03.003. Epub 2015 Apr 3. Cancer Epidemiol. 2015. PMID: 25843691

5

Isolation and characterization of adult mammary stem cells from breast cancer-adjacent tissues.

Shi AP, Fan ZM, Ma KW, Jiang YF, Wang L, Zhang KW, Fu SB, Xu N, Zhang ZR. Shi AP, et al. Among authors: xu n. Oncol Lett. 2017 Sep;14(3):2894-2902. doi: 10.3892/ol.2017.6485. Epub 2017 Jun 28. Oncol Lett. 2017. PMID: 28927044 Free PMC article.

6

Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer.

Li W, Yang H, Li X, Han L, Xu N, Shi A. Li W, et al. Among authors: xu n. Oncol Rep. 2019 Jan;41(1):437-446. doi: 10.3892/or.2018.6805. Epub 2018 Oct 18. Oncol Rep. 2019. PMID: 30365081

7

Up-regulation of LIMK1 expression in prostate cancer is correlated with poor pathological features, lymph node metastases and biochemical recurrence.

Huang JB, Wu YP, Lin YZ, Cai H, Chen SH, Sun XL, Li XD, Wei Y, Zheng QS, Xu N, Xue XY. Huang JB, et al. Among authors: xu n. J Cell Mol Med. 2020 Apr;24(8):4698-4706. doi: 10.1111/jcmm.15138. Epub 2020 Mar 13. J Cell Mol Med. 2020. PMID: 32168432 Free PMC article.

8

Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer.

Xu N, Chen HJ, Chen SH, Xue XY, Chen H, Zheng QS, Wei Y, Li XD, Huang JB, Cai H, Sun XL. Xu N, et al. Medicine (Baltimore). 2016 Jul;95(29):e4326. doi: 10.1097/MD.0000000000004326. Medicine (Baltimore). 2016. PMID: 27442684 Free PMC article.

9

Reduced Connexin 43 expression is associated with tumor malignant behaviors and biochemical recurrence-free survival of prostate cancer.

Xu N, Chen HJ, Chen SH, Xue XY, Chen H, Zheng QS, Wei Y, Li XD, Huang JB, Cai H, Sun XL. Xu N, et al. Oncotarget. 2016 Oct 11;7(41):67476-67484. doi: 10.18632/oncotarget.11231. Oncotarget. 2016. PMID: 27623212 Free PMC article.

10

Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.

Wu YP, Chen SH, Wang ST, Li XD, Cai H, Lin YZ, Xue XY, Wei Y, Zheng QS, Xu N. Wu YP, et al. Among authors: xu n. Oncotarget. 2017 Apr 25;8(17):29048-29055. doi: 10.18632/oncotarget.16070. Oncotarget. 2017. PMID: 28423709 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,950 results

Search Page

Filters